Who Is Buying Oracle? Hedge Fund Activity in 2026

Oracle Corporation has quietly become one of the most compelling stories in enterprise technology. The company's aggressive push into cloud infrastructure, combined with its AI partnerships and a database business that remains the backbone of enterprise IT, has attracted significant institutional attention. With Larry Ellison's vision driving Oracle deeper into the AI infrastructure race, hedge funds are taking notice.

The latest 13F filings tell a strong story: 9 out of 20 tracked funds are buying Oracle while only 4 are selling. That's a decisive tilt toward accumulation among the world's most sophisticated investors.

Oracle Institutional Snapshot

A buy-to-sell ratio above 2:1, combined with $70 billion in total institutional value across tracked funds, positions Oracle as one of the most institutionally favored enterprise tech names in 2026.

Who's Buying Oracle in 2026?

Vanguard Group — $25.6B (Increased)

Vanguard leads the pack with an enormous $25.6 billion Oracle position. The increase reflects both Oracle's growing market cap weight in indices and Vanguard's active fund managers seeing continued upside in the cloud transformation story.

State Street Global Advisors — $11.2B (Increased)

State Street boosted its Oracle holdings to $11.2 billion, reinforcing the institutional consensus around ORCL. As the second-largest tracked holder, State Street's increase confirms Oracle's prominence in institutional portfolios.

Citadel Advisors (Ken Griffin) — $415.9M (Increased)

Citadel increased its Oracle stake to $415.9 million. Griffin's multi-strategy fund has been systematically building exposure to enterprise cloud names, and Oracle's OCI (Oracle Cloud Infrastructure) growth appears to be a key thesis driver.

Bridgewater Associates — $274.2M (Increased)

Bridgewater's increase to $274.2 million is notable given the fund's macro-driven approach. Oracle's recurring revenue model and mission-critical database business offer the kind of defensive growth characteristics that Bridgewater's risk-parity models favor.

Appaloosa Management (David Tepper) — $248.1M (Increased)

David Tepper is adding to Oracle, bringing Appaloosa's position to $248.1 million. Tepper's willingness to increase exposure suggests he sees Oracle's valuation as still reasonable relative to its cloud growth trajectory and AI infrastructure partnerships.

Millennium Management — $142.3M (Increased)

Millennium boosted its Oracle position to $142.3 million. The fund's independent portfolio teams are finding alpha opportunities in Oracle's transition from legacy licensing to cloud subscriptions.

D.E. Shaw — $140M (Increased)

D.E. Shaw increased to $140 million in Oracle. The quantitative giant's models appear to favor ORCL's momentum and fundamental metrics, particularly revenue acceleration in cloud services.

Two Sigma — $108.5M (Increased)

Two Sigma added to its Oracle position, now at $108.5 million. The algorithmic fund's increase aligns with the broader quant consensus that Oracle's financial metrics are trending in the right direction.

Who's Selling Oracle?

Coatue Management (Philippe Laffont) — $649.9M (Decreased)

Coatue remains one of the larger hedge fund holders at $649.9 million but trimmed its position. Laffont's tech-focused fund may be rebalancing after Oracle's strong run, rotating capital into other AI infrastructure plays or taking profits at current valuations.

Baker Bros Advisors — $77.4M (Decreased)

Baker Bros reduced its Oracle stake to $77.4 million. While primarily known for healthcare investments, Baker Bros' trim may reflect portfolio-wide rebalancing rather than a fundamental bearish call on Oracle.

Canyon Capital — $2.9M (Decreased)

Canyon made a small reduction, bringing its Oracle position down to just $2.9 million — a minimal holding that may be headed for a full exit in coming quarters.

Renaissance Technologies — SOLD Entire Position

Renaissance completely exited Oracle, selling its entire position. This is a significant move from the world's most successful quant fund. Jim Simons' models clearly reached a sell signal on ORCL, though this contrasts sharply with other quants like D.E. Shaw and Two Sigma who are increasing.

Notable Moves

The Quant Divergence on Oracle

Perhaps the most fascinating aspect of Oracle's institutional activity is the split among quantitative funds. D.E. Shaw and Two Sigma are buying while Renaissance Technologies has completely exited. This kind of quant divergence typically occurs when a stock is transitioning between regimes — in Oracle's case, from a legacy enterprise company to a cloud and AI infrastructure player. Different models weigh this transition differently.

Broad-Based Hedge Fund Buying

What stands out is the breadth of buying. Citadel, Bridgewater, Appaloosa, Millennium, D.E. Shaw, and Two Sigma are all increasing — these are fundamentally different types of funds (macro, multi-strategy, event-driven, quant) arriving at the same bullish conclusion. When diverse investment approaches converge on the same stock, it's a powerful signal.

7 Funds Holding Steady

The large number of funds maintaining their positions (7 out of 20) adds stability. These funds have chosen not to sell despite Oracle's appreciation, suggesting they see more upside ahead.

What This Signals

Oracle's 13F data reveals one of the strongest institutional buying signals in enterprise technology. A 9-to-4 buying advantage, combined with the diversity of funds accumulating shares, paints a compelling picture.

The bull case is straightforward: Oracle Cloud Infrastructure is gaining market share in AI workloads, the database business provides a massive recurring revenue base, and Larry Ellison's partnerships with major AI companies are translating into real revenue growth. With $70 billion in institutional value across tracked funds, the smart money clearly sees Oracle as a core holding, not a speculative bet.

The bear case centers on Coatue's trim and Renaissance's full exit. When a $649.9 million holder reduces and the world's best quant fund sells entirely, it deserves attention. However, these moves are outweighed by the sheer number of funds on the buy side.

The 7 holding funds represent a stable base of institutional ownership that isn't going anywhere. Combined with the active buying, Oracle's institutional ownership structure looks healthy and supportive of continued appreciation.

For investors watching institutional flows, Oracle's message is clear: the smart money is betting on Oracle's cloud and AI transformation, and the consensus is building rather than fading.

Track Oracle Institutional Activity

Track ORCL institutional moves in real-time with Freenance Smart Money — we track 35 funds with $21.4T total AUM across 77,111 positions. See who's buying and selling at app.freenance.io/smart-money/ticker/ORCL.

Related Articles

• Who Is Buying NVIDIA? Hedge Fund Activity in 2026
• Who Is Buying Apple? Hedge Fund Activity in 2026
• Who Is Buying Tesla? Hedge Fund Activity in 2026

FAQ

Why are hedge funds buying Oracle in 2026?

The dominant thesis is Oracle Cloud Infrastructure (OCI) winning AI workloads, including a multi-year capacity deal with OpenAI and other generative-AI tenants. Combined with a sticky database moat and high-margin recurring licensing, that mix gives funds a defensive growth profile that is rare in big-cap tech.

What does the OpenAI deal mean for ORCL institutional flows?

The reported multi-year cloud capacity commitment turned Oracle from a "legacy database" name into an AI infrastructure story almost overnight. That re-rating is exactly the kind of regime change quants and macro funds like Citadel, Bridgewater and Appaloosa try to front-run, which shows up in the 9-to-4 buy/sell tilt in the latest 13F filings.

Why did Renaissance Technologies sell its entire Oracle position?

Renaissance is a pure systematic fund — exits and entries reflect model signals, not a human view on Oracle's business. A full liquidation typically means short-term factor signals (momentum, valuation, mean reversion) tipped against ORCL even as fundamentally driven funds like D.E. Shaw and Two Sigma stayed on the buy side.

Is Oracle still a "value" stock or is it priced as an AI name?

After the recent run, Oracle trades closer to a cloud-growth multiple than a legacy software multiple. Funds adding here are effectively saying OCI revenue growth and AI capacity bookings can justify that multiple, while sellers like Coatue are taking profits because the easy re-rating leg may already be in the price.

How can I track ORCL hedge fund activity over time?

Freenance Smart Money parses SEC 13F filings from major funds and shows quarter-over-quarter changes per ticker. For ORCL you can see who is buying, selling and holding, plus the absolute dollar value of each position, which is more useful than a single headline number when you want to follow institutional conviction.